Your session is about to expire
← Back to Search
Smoking Cessation Algorithm for HIV/AIDS Patients
Study Summary
This trial is testing whether an algorithm can help primary care providers of smokers with HIV/AIDS recommend smoking cessation-related pharmacotherapy options.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not speak English.I am able to understand and give consent for my treatment.I am currently undergoing treatment to stop smoking.You are currently experiencing extreme mental distress, such as feeling suicidal or manic, or have recently consumed drugs or alcohol that may affect your decision-making ability.I am 18 years old or older.You have smoked at least 5 cigarettes every day for the last month.You live in a place where smoking is allowed without any restrictions.
- Group 1: Algorithm Treatment plus referral to quitline (AT)
- Group 2: Quitline (eTAU)
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How risky is Algorithm Treatment for those who opt-in?
"Algorithm Treatment received a score of 3, as this Phase 4 trial is approved and data supports the treatment's safety."
Are there any participatory vacancies in this research endeavor?
"That is accurate. Per the information on clinicaltrials.gov, this medical research project was initially posted on August 17th 2020 and it has been actively seeking 600 participants from one centre ever since its last update on August 30th 2022."
What is the uppermost limit for participatory subjects in this trial?
"Affirmative, according to clinicaltrials.gov this trial is still looking for participants who can join the research team at one medical centre. The study was initially posted on August 17th 2020 and most recently updated on August 30th 2022 with a goal of recruiting 600 patients in total."
Share this study with friends
Copy Link
Messenger